DatasetName,EIF4G3_M(164) EIF4G3_S(1) EIF4G3_S(1110) EIF4G3_S(1112) EIF4G3_S(1157) EIF4G3_S(1165) EIF4G3_S(1218) EIF4G3_S(1598) EIF4G3_S(1605) EIF4G3_S(164) EIF4G3_S(2) EIF4G3_S(231) EIF4G3_S(267) EIF4G3_S(3) EIF4G3_S(4) EIF4G3_S(419) EIF4G3_S(421) EIF4G3_S(684) EIF4G3_T(1113),EIF4G3_C(304) EIF4G3_C(305) EIF4G3_S(1115) EIF4G3_S(1131) EIF4G3_S(1156) EIF4G3_S(1192) EIF4G3_S(1407) EIF4G3_S(1409) EIF4G3_S(1411) EIF4G3_S(1412) EIF4G3_S(1445) EIF4G3_S(1479) EIF4G3_S(1582) EIF4G3_S(229) EIF4G3_S(230) EIF4G3_S(232) EIF4G3_S(240) EIF4G3_S(493) EIF4G3_S(494) EIF4G3_S(495) EIF4G3_S(501) EIF4G3_S(567) EIF4G3_T(1116) EIF4G3_T(1198) EIF4G3_T(168) EIF4G3_T(179) EIF4G3_T(518)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.45438416915302876,
FSO2013_Ratio M/L normalized Rep3,,0.5465815772242163
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5493918980159852
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,0.5533030586229095
ZX2022_Control Replicate 2,,0.5529530594483612
HS2024_6_B_T3,,
JW2015_Intensity pre1,0.456964510955922,0.5561570935761557
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5675252991621096
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5597972233143117
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.45977382485462787,0.5627337518098324
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.5676572274695632
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.4609966306310853,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.4639671950028823,0.5520737106398271
WZ2023_Pu_010_30min,0.46093192146274925,0.5628911665942994
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.4599489901095938,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5576546610521986
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5496999543809693
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.4552429392332311,
PG2020_Intensity 8h_C,,0.5468393770538261
AH2018_SILAC_MR_2_N,,0.5524777964812355
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5532582635619435
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.5549660886441778
FSO2013_Ratio H/L normalized Rep2___2,,0.5542700056976068
EP2017_Pervanadate R#3 normalized log2 ratio,0.4483520333829992,0.5448991247104396
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.4580083417605249,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.456482964198905,
GF2025_P6_Sph,,0.5658506842215293
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5531812533535394
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.45478369467064755,0.5656634343438378
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.46218749264302833,0.5627238229789203
WZ2023_Pu_005_10min,0.4570201594403736,0.5712644824426961
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.557976203699515
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5538450391123434
WZ2023_Pu_025_30min,0.4558877744547532,0.568098303004055
AH2018_SILAC_MR_2_X,,0.554285923340368
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5593026407818752
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.4460387321801779,
EJN2021_3_Rest_Basal,0.45970592301049185,0.5564184012324765
CR2017_Ratio Replicate 1.3,,0.5701544309072073
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5443254264356758
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5548624473590915
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5586264620886117
AH2018_LFQ_1_C,,0.5563330523293814
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.4548336108475513,0.5656803206412921
CK2022_11 40-1,,0.5581046118381532
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5549090978476097
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5573565497451562
FSO2013_Ratio H/L normalized Rep2,,0.5687779694783036
WZ2023_Pu_005_20min,0.4596723930132983,0.5713581131543322
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5604103194396823
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5572166173742512
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.5537648008713295
PG2020_Intensity Mock_10h_D,,0.5461837627568674
SR2019_MCF10A_Biol_repl_2,0.45640091922291215,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4530736151582987,0.5556563969499904
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,0.5536110581329735
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5660998398843538
PG2020_Intensity 2h_C,,0.5411719182826281
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5536201264176884
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5533933491966435
CK2022_3 40-1,,0.5571268198965618
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.45565121324317426,0.5513638759642938
HH2022_Reporter intensity 8,,0.5539435754187595
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5612315382728513
EJN2021_5_Rest_Basal,0.4599806090756483,0.554928187436875
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5458441819887001
YA2020_Reporter_intensity_Normal_No.1,0.4548834359070367,0.5520103007491068
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.4571369986143981,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5563959178534102
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.4600090906549969,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5649182686180616
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5502708702937542
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.4549090492475621,0.5713071168483558
HS2024_6_PD_T3,,
DL2023_12h-2,,0.5556095645123185
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4523964879351474,0.5663245214497595
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5566378335698791
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.5578083336909422
RB2022_4_RecoveryEndurance,0.45230698761146576,
RB2022_5_RecoveryEndurance,0.44644678409787414,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5502428962597492
FSO2013_Ratio H/M normalized Rep2,,0.5519475426913057
RAM2015_Log2 A,,0.5564982450463115
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.5525975093031408
KS2014_Intensity E15_2,,0.5583745642068823
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5489512949231019
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5456701253652697
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5530455664037187
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.464077204212527,0.5523193144807089
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.5619642243869969
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.45357010684494514,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.554725871251263
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,0.5590566501324468
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5545048429400296
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.5582575772258825
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5537132513584783
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5556919375125217
DL2023_control-1,,0.5523867339345846
AR2021_ALG 10 μM,0.4511387605804383,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5451148391211118
EJN2021_4_Rest_Ins,0.4592118517262765,0.5565592720632062
RN2012_H05,,0.5537194092848265
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5570411285526886
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.4600410520263769,0.5556077837613945
HH2022_Reporter intensity 3,,0.5528769004328367
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5507982486367832
JW2021_After_3,,0.5595142655614791
GF2025_P8_Sph,,0.5671098221365362
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5546985515244492
CK2022_11 200-1,,0.5575745374499778
CK2022_12 200-1,,0.5562815976881131
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.556588326367834
WZ2023_Su_010_20min,0.4513181391049074,0.5643438244080522
AH2018_TMTMS2_2_N,,0.5499111906276747
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.4574023010505048,0.5608364263084007
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.4681887425752985,
AH2018_TMTMS3_Pool,,0.560217215506691
KS2014_Intensity N4,,0.5578578747870073
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.5507689520321957
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.5536931809364085
CK2022_14 200-1,,0.5542145724219856
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.4460656429075549,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5632483157758883
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.530383638089837
JW2021_After_2,,0.5618477623382493
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.45886317806707094,0.5540235548913683
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,0.5569373131794232
GF2025_P1_Sph,,0.5583245624035311
EJN2021_5_Ex_Basal,0.45824742022825893,0.5541846109324088
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.45179916018754906,0.5658605777819763
CF2017_EOC 1,,0.5536529416190522
CK2022_3 200-1,,0.554465160843333
AH2018_LFQ_IT_3_C,,0.5549927487535523
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.45322201489788366,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,0.5550654730803601
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5567515950048338
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5544154055264944
JW2021_Before_2,,0.5470888466705017
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.4518672818702946,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.45936843763714424,0.5546730536337966
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.5639029304480244
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5581207097469987
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.5539913889705952
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5488609005734298
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,0.5582492826079022
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.46396264158641576,0.5694665945278754
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.45896434945260917,0.5615274852935458
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5548948626838694
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5599405172357922
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.5520997886027518
KBE2022_Log2_Ex_27_U,,0.5624485948033707
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5506813292143169
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.4519141833852052,
YA2020_Reporter_intensity_Normal_No.4,0.45651868000778156,0.5436661288054018
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5500910965009771
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.5561721515856722
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5552945822104294
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5579542104279245
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5612242183484002
HH2022_Reporter intensity 6,,0.5580891369856674
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5603871595273747
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5491973474320115
GF2025_P3_Adh,,0.5513236586348685
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5549273409762365
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5474622600300777
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.4475799686477843,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5464335174336865
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5587156532830166
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.45917039356954775,
RB2022_7_RecoverySprint,0.46171754441291724,
YA2020_Reporter_intensity_Normal_No.3,0.45828874205352577,0.5457893929880795
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.5568037099283388
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.559982010670976
HH2022_Reporter intensity 1,,0.5527900183564809
HH2022_Reporter intensity 2,,0.5531929305106206
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.4549497563190002,0.551586542096121
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.45459513124415873,0.5353490555673789
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.45688569319996,
CR2017_Ratio Replicate 2,,0.5584637996685738
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5637100102167406
AR2021_KD 72h,0.46222710281718915,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.5561498915450787
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5618512897412818
KBE2022_Log2_Ex_9_U,,0.5565120977788149
AH2018_SILAC_M_3_N,,0.5465835749004282
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5492039849712066
CF2017_OSE 29,,0.5493012630209277
YB2013_Ratio_H_L_Normalized_in_experiment_1,,0.551822789479347
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,0.5527721508623787
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5461763517516836
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5555445287508058
JW2015_Intensity cap2,0.4571244302517298,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5573899206614448
RB2022_7_RecoveryEndurance,0.45923664058645314,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.4583520169380535,0.555212744004242
TM2022_S2.12h.B,,
RN2012_L15,,0.5523390570424609
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5551319139737322
FSO2013_Ratio H/M normalized Rep2___2,,0.5550994316114984
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4576546387705558,0.5605332545513275
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5596896317682477
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.556413844384659
CK2022_5 200-1,,0.555622002956868
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5702740883550994
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5509732032962219
AH2018_SILAC_MR_1_X,,0.5543405824924829
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.45688956760223587,0.5591939435140534
AH2018_SILAC_3_C,,0.5461779345983151
EJN2021_5_Rest_Ins,0.4592006853982767,0.5555995765918721
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5513871947257311
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.45729745265917926,0.5550417739373712
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5496292669544454
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,0.5393268167807602
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.5484439848742173
FSO2013_Ratio H/L normalized Rep3,,0.5642798845090605
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,0.5636825523788519
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.5558702335212209
AH2018_SILAC_IT_2_N,,0.5435488081221075
AH2018_SILAC_IT_1_X,,0.5548771357463761
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.5553785553045357
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5635605354864072
WZ2023_Pe_025_20min,0.4550757004475469,0.5701646779430587
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5549093150981174
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5497920797474275
RN2012_H06,,0.5524083681987898
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.4561862172548554,0.5671039502091464
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.5554703048919952
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5466881307818608
WZ2023_Su_025_10min,0.4585519053735276,0.5678276047951388
AH2018_LFQ_IT_4_X,,0.5443268166105282
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.4556187373821393,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.46194481717012176,0.5712356118971231
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.4566672707455435,0.5509655855541387
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.5547041228775913
EP2017_Pervanadate R#1 log2 ratio,0.4508454707322548,0.5450176658322382
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.5601624132212379
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5446183162913856
LY2019_P7+,,0.5522693752655452
EP2017_Untreated R#1 normalized log2 ratio,0.45700722316054754,0.5497139199842467
RN2012_L10,,
PG2020_Intensity 4h_C,,0.540768690919454
EP2017_Mitotic R#3 normalized log2 ratio,0.4546678320866987,0.5588468263811885
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.4564440097590091,0.561119845928165
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.554852107151139
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.4584065260817609,0.534095028773431
CR2017_Ratio Replicate 1.1,,0.5595653991648258
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5538641952156402
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4536224082735453,0.5585463482416712
GF2025_P9_Sph,,0.5608540499732063
CK2022_6 200-1,,0.5557663116887654
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5633654888314874
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,0.45692668541213316,0.5546721524175728
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.5518243202741511
PG2020_Intensity 2h_D,,0.5335848282951
EP2017_Untreated R#3 normalized log2 ratio,0.46001928716034163,0.5628376246177821
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5564791839575137
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5605640037495591
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.45175216791821954,0.5309206481637845
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5550084083421316
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.5573245731093339
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.4580361914656416,0.5556614567188561
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.554833496330133
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.554616014281972
PG2020_Intensity CT_C,,0.5387765892687314
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.4601154435544087,0.5633070982613938
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5657608468421321
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.45509963896465516,
CR2017_Ratio Replicate 2.3,,0.5580597606257977
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5568583671904813
YA2020_Reporter_intensity_Normal_No.2,0.45596687145315085,0.5512927469619483
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.5548368285422436
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5502817939877437
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,0.5545105503646164
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.45940383635371806,0.5555679049649679
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.5549306822229642
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,0.4549051595567482,0.5548290373200357
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,0.5489589930547464
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.5501906796819932
WZ2023_Su_025_30min,0.4592576354517784,0.5685478973724482
AH2018_LFQ_4_N,,0.5547912096560106
CR2017_Ratio Replicate 1.2,,0.5612927049331456
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5592247585999898
AH2018_SILAC_M_1_X,,0.5510412450020418
RB2022_7_PreEndurance,0.45717337986614154,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,0.5547108976641605
LY2019_P6+,,0.5549722509663523
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5439671383094373
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5638653393773334
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.5583562670972438
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5395350745854943
RB2022_3_PostStrength,0.44729124137121323,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5557984161508652
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5485233856122766
AH2018_LFQ_2_X,,0.5551412482953092
PG2020_Intensity 2h_B,,0.5408757887245035
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.4581452190443411,
KS2014_Intensity E15_3,,0.5562120040167933
GF2025_P3_Sph,,0.563768822624779
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5494018122693214
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4572335833891706,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5452276901629852
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.45547080105205756,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5584179634538683
ZQ2022_N1,,
LY2019_P6-,,0.5554041205787702
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.555383011411997
JW2015_Intensity pre2,0.4553802516570843,0.5549613595941366
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5551955437277213
AH2018_LFQ_3_N,,0.5550897307150348
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.45463382674983965,0.5571506136772404
UK2020_UA_1,,0.5552514227749596
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.5574576104226077
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5467995065841429
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.4509926303358658,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.4610463586809516,0.5634842457966337
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5505621258491254
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5547476806659404
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5582663246679034
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.45808848079705156,0.5554161123709834
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.45886011379673575,0.5545452965973663
EP2017_Pervanadate R#3 log2 ratio,0.4484730837912401,0.5453301879448054
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.5481027596263606
AH2018_LFQ_M_4_C,,0.5443186397535236
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,0.555234815023257
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5547494140504943
CK2022_6 40-1,,0.5574953276283228
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.5616622020354289
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.45891845428873207,0.5560832232426833
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4514597260971595,0.5637474076398116
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.45848068528858515,0.5559599953258834
AST2020_Control.1,,
JW2015_Intensity cap1,0.456627967611173,0.5557897303473851
PG2020_Intensity CT_A,,0.5269662001075832
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.45510728417644053,0.5646480411432889
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5612491511868379
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5529364211549344
RB2022_4_PreSprint,0.44829907030058785,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5593657568914308
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5505589480569673
LY2019_P8+,,0.5545884133304421
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.4519597106709572,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.4595874622730254,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5544114368231502
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5516111412719655
LY2019_P2-,,0.5597460997045571
AH2018_LFQ_IT_1_X,,0.5506571569384403
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4536060725124583,0.5672991776913479
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.556782190246698
SR2019_MCF10A_Biol_repl_4,0.4573047803179632,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5522409004089067
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.5588977072767443
AH2018_TMTMS3_3_N,,0.5585176346773186
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5555974008080494
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.45435933369552006,0.5572537209435775
KBE2022_Log2_Ex_36_T,,0.5582577792166384
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4612288218221759,0.5691508156270235
KS2014_Intensity C2,,0.560441452642374
FSO2013_Ratio H/L normalized Rep1___2,,0.553633017166029
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,0.5573594982059557
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.558526017351444
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.5591055067672588
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.5626710310268294
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5517381711997904
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.4608174541567532,0.5566850539271182
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,0.5604734034981075
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.45710395598586895,0.5501095614389855
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.4590795971932183,0.5715802169155658
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.5525624751700745
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5597731455171845
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5547466973686269
LATM2013_Log2 Ratio (Medium/Light) Forward,0.45488984227438567,0.5713020186141485
PG2020_Intensity 2h_A,,0.5475947158826484
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5549152124066571
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.46303231201702894,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.4565521147171773,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.45443087546116306,0.5648897052909116
KBE2022_Log2_Ex_29_U,,0.5567325384746199
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5511503933883192
AH2018_LFQ_IT_4_N,,0.5458463732747754
CK2022_15 200-1,,0.5542087571912633
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.46159482605734103,0.562394654964987
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5522033432463904
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.45842249034569854,0.5317818564399487
CK2022_2 200-1,,0.5537483962858768
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.4595969409301309,0.5708531120562662
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.4577767344081531,0.5539134604822636
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.558959112858468
EP2017_Pervanadate R#1 normalized log2 ratio,0.45074132240558057,0.5446116614015645
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.45791511168276516,0.5519762117208207
KBE2022_Log2_Ex_44_U,0.4592939707815528,0.5629384124849268
WZ2023_Pe_010_20min,0.4544144319339688,0.5652875304079599
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.4602201747238339,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.5595980260653198
FSO2013_Ratio H/M normalized Rep3___1,,0.5610210627431454
AH2018_SILAC_M_3_C,,0.5470139228057336
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5551662130429503
AH2018_SILAC_M_2_X,,0.5547257807143171
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4559442497570809,0.5657234077401354
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5514866800165938
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5484611742165113
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,0.5480061838025414
FSO2013_Ratio H/L normalized Rep3___2,,0.555403649804754
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.546422134737709
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5651113351260427
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.44562379680832914,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.5558325139081463
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.45298305359520663,0.5560978175301435
EJN2021_2_Ex_Basal,0.45856298928954226,0.5549970222253168
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5509802429041284
AR2021_L41 10 μM,0.4528020499947269,
CF2017_EOC 2,,0.5554468502114517
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5502606235869076
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.5550000236114551
RB2022_7_PreSprint,0.4560981318525477,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.5540664347851934
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.553144303582945
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5527357651886307
AR2021_L41 1 μM,0.4568614981651127,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.552658370374738
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5533540939611046
KS2014_Intensity C4,,0.5600325374221592
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.5544677753641004
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,0.45525880318151984,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.551192237117236
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5477979443108081
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.5508535125702904
WZ2023_Pu_025_10min,0.4545608117420044,0.5668603470947823
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5463839419946341
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.5595470312006019
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.45419518657967556,0.5658461573283984
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5546823431859367
KS2014_Intensity C6,,0.5606856360694514
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5584938692621625
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5545648799783044
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5584306980956514
AH2018_SILAC_IT_2_C,,0.5513163535550785
CK2022_5 40-1,,0.5574476634639688
AH2018_LFQ_3_X,,0.5555576789476744
UK2020_UA_3,,0.5553242690892837
LY2019_P7-,,0.5597723456604558
GF2025_P5_Adh,,0.5587759943494699
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5656081827456108
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.5678697591092214
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.567463565351977
PG2020_Intensity CT_B,,0.5433616242812267
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5550328122221737
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,0.5467827184686191
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.45278029940408643,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5551262918916163
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5565166518606456
YA2020_Reporter_intensity_Cancer_No.4,0.4563981965932859,0.5515302452977284
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5600848199437554
RB2022_2_PreEndurance,,
JW2021_Before_1,,0.5527751024886418
KBE2022_Log2_Ex_25_T,0.4570639015720299,0.5603810303521093
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5518949866274374
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.4572665150574002,
EP2017_Mitotic R#2 log2 ratio,0.45255485509514193,0.5534386129348583
AH2018_TMTMS2_1_X,,0.5541951192040527
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.4574674195349228,0.5545590086806934
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.5584639533154088
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.55334010752246
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5506651238907737
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.5636055238632397
CF2017_FTE 14,,0.5546006811165226
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5541590617300387
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.4545333633358397,0.5350043835820936
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5550951829682033
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.45192007410308305,0.5315785917633161
AS2011_Ratio H/L Normalized RNAi_2_1,,
